CM
MRTX

Crestline Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Crestline Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-26,212
Closed -$805K – 296
2018
Q1 		$805K Buy
+26,212
New +$805K 0.1% 166